According to a market report by Lucintel, the future of the global acute spinal cord injury market looks promising with opportunities in the hospital and trauma center markets. The global acute spinal cord injury market is expected to reach an estimated $10 billion by 2030, at a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are growing awareness towards the benefits of early treatment, rising incidence of acute spinal cord injury, and growing popularity of extreme sports activities across the globe.
A more
than 150-page report to understand trends, opportunity and forecast in global acute
spinal cord injury market to 2030 by type (complete spinal cord injury and
incomplete spinal cord injury), end use (hospitals and trauma centers), and
region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel
forecasts that incomplete spinal cord injury (ISCI) will remain the larger
segment over the forecast period due to increasing incidence of spinal cord
injuries and growing awareness towards treatment of spinal cord injuries.
Within
this market, hospital is expected to remain the larger segment due to growing
number of inpatient rehabilitation programs at hospitals to deliver
comprehensive services to help people.
Download
sample by clicking on acute
spinal cord injury market.
North
America will remain the largest region due to surge in aging population,
well-developed healthcare system, and increasing adoption of advanced
technologies in the region.
Novartis,
Tenax Therapeutics, Accure Pharma, Acorda Therapeutics, Asterias
Biotherapeutics, ReNetX Bio, BioArctic, BioTime, InVivo Therapeutics, Kringle
Pharma are the major suppliers in the acute spinal cord injury market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal, ZACKS,
and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Bi-Color Light-Emitting Diode(LED) Market
Bitcoin Automated Teller Machine (ATM) Market
No comments:
Post a Comment